Aquestive Therapeutics SG&A Expense (Quarterly) Insights

Aquestive Therapeutics Inc (AQST)

3.28 +0.06 (+1.86%) USD | NASDAQ | May 16, 16:00

3.13 -0.15 (-4.57%) After-Hours: 05:59

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	10.69M
December 31, 2023	9.55M
September 30, 2023	7.385M
June 30, 2023	7.36M
March 31, 2023	7.455M
December 31, 2022	11.81M
September 30, 2022	12.46M
June 30, 2022	15.59M
March 31, 2022	13.02M
December 31, 2021	14.98M
September 30, 2021	12.13M
June 30, 2021	13.13M
March 31, 2021	13.23M
December 31, 2020	15.58M
September 30, 2020	11.80M

Date	Value
June 30, 2020	13.89M
March 31, 2020	14.61M
December 31, 2019	16.47M
September 30, 2019	13.71M
June 30, 2019	16.25M
March 31, 2019	17.91M
December 31, 2018	18.71M
September 30, 2018	12.35M
June 30, 2018	33.67M
March 31, 2018	7.569M
December 31, 2017	7.565M
September 30, 2017	6.161M
June 30, 2017	5.223M
March 31, 2017	6.128M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

7.36M

Minimum

Jun 2023

16.47M

Maximum

Dec 2019

12.56M

Average

13.08M

Median

SG&A Expense (Quarterly) Benchmarks